|
Mayo Clinic eMERGE III Implementation |
Diverticulosis and Diverticulitis |
Mayo Clinic |
Case, Control |
3,679 |
2,459 |
|
|
|
GHUW Diverticulitis |
Diverticulosis and Diverticulitis |
GHRI/UW |
Case, Control |
|
|
|
|
|
NU e3 Diverticulosis |
Diverticulosis and Diverticulitis |
Northwestern University |
Case, Control |
1,273 |
1,211 |
|
|
|
Diverticulosis May 2012 Implementation |
Diverticulosis and Diverticulitis |
Northwestern University The Feinberg School of Medicine |
Case, Control |
|
|
98%, 89% |
99%, 98% |
|
Vanderbilt evaluation for Diverticulosis |
Diverticulosis and Diverticulitis |
Vanderbilt University |
Case Only |
|
|
88% |
|
|
Marshfield diverticulosis/diverticulitis implementation |
Diverticulosis and Diverticulitis |
Marshfield Clinic Research Foundation |
Case, Control |
50 |
50 |
100%, 100% |
|
|
Network Combined Dataset - Diverticulosis |
Diverticulosis and Diverticulitis |
|
Case, Control |
6,173 |
4,969 |
|
|
|
Diverticulosis Implementation - Columbia |
Diverticulosis and Diverticulitis |
Columbia University |
Case, Control |
66 |
689 |
|
|
|
VUMC ACEi cough implementation |
ACE Inhibitor (ACE-I) induced cough |
Vanderbilt University |
Case, Control |
|
|
100%, 100% |
96% |
|
Validation of ACEi-induced cough algorithm |
ACE Inhibitor (ACE-I) induced cough |
Mayo Clinic |
Case, Control |
|
|
100%, 96% |
|
|
NU ACE Inhibitor (ACE-I) induced cough implementation |
ACE Inhibitor (ACE-I) induced cough |
Northwestern University The Feinberg School of Medicine |
Case, Control |
|
|
100%, 98% |
|
|
Marshfield ACE-I cough implentation |
ACE Inhibitor (ACE-I) induced cough |
Marshfield Clinic Research Foundation |
Case, Control |
25 |
25 |
100%, 96% |
|
|
Network Combined Dataset - ACE-I induced Cough |
ACE Inhibitor (ACE-I) induced cough |
|
Case, Control |
|
|
|
|
|
ACEi Cough Implementation - Columbia |
ACE Inhibitor (ACE-I) induced cough |
Columbia University |
Case, Control |
17 |
233 |
|
|
|
Clopidogrel Poor Metabolizers-Columbia |
Clopidogrel Poor Metabolizers |
Columbia University |
Case Only |
|
|
|
|
|
Demonstration Project AF Implementation |
Atrial Fibrillation - Demonstration Project |
Vanderbilt University |
Case, Control |
|
|
98%, 100% |
|
|
Demonstration Project Crohn's Disease Implementation |
Crohn's Disease - Demonstration Project |
Vanderbilt University |
Case, Control |
|
|
100%, 100% |
|
|
Demonstration Project MS Implementation |
Multiple Sclerosis - Demonstration Project |
Vanderbilt University |
Case, Control |
|
|
87%, 100% |
|
|
Demonstration Project RA Implementation |
Rheumatoid Arthritis - Demonstration Project |
Vanderbilt University |
Case, Control |
|
|
97%, 100% |
|
|
Demonstration Project T2D Implementation |
Type 2 Diabetes - Demonstration Project |
Vanderbilt University |
Case, Control |
|
|
100%, 100% |
|
|
CDiff NU implementation - May 2012 chart review |
Clostridium Difficile Colitis |
Northwestern University |
Case, Control |
|
|
90%, 95% |
95% |
|
Group Health implementation |
Clostridium Difficile Colitis |
Group Health Cooperative |
Case, Control |
|
|
92%, 88% |
|
|
Vanderbilt implementation |
Clostridium Difficile Colitis |
|
Case, Control |
|
|
100%, 100% |
|
|
Marshfield C-diff implementation |
Clostridium Difficile Colitis |
Marshfield Clinic Research Foundation |
Case, Control |
21 |
10 |
100%, 100% |
|
|
CDiff Implementation - Columbia |
Clostridium Difficile Colitis |
Columbia University |
Case, Control |
107 |
139 |
|
|
